Correlation Between Corcept Therapeutics and Nuvalent
Can any of the company-specific risk be diversified away by investing in both Corcept Therapeutics and Nuvalent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corcept Therapeutics and Nuvalent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corcept Therapeutics Incorporated and Nuvalent, you can compare the effects of market volatilities on Corcept Therapeutics and Nuvalent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corcept Therapeutics with a short position of Nuvalent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corcept Therapeutics and Nuvalent.
Diversification Opportunities for Corcept Therapeutics and Nuvalent
0.11 | Correlation Coefficient |
Average diversification
The 3 months correlation between Corcept and Nuvalent is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Corcept Therapeutics Incorpora and Nuvalent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvalent and Corcept Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corcept Therapeutics Incorporated are associated (or correlated) with Nuvalent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvalent has no effect on the direction of Corcept Therapeutics i.e., Corcept Therapeutics and Nuvalent go up and down completely randomly.
Pair Corralation between Corcept Therapeutics and Nuvalent
Given the investment horizon of 90 days Corcept Therapeutics Incorporated is expected to generate 1.7 times more return on investment than Nuvalent. However, Corcept Therapeutics is 1.7 times more volatile than Nuvalent. It trades about 0.26 of its potential returns per unit of risk. Nuvalent is currently generating about 0.14 per unit of risk. If you would invest 5,006 in Corcept Therapeutics Incorporated on September 4, 2024 and sell it today you would earn a total of 915.00 from holding Corcept Therapeutics Incorporated or generate 18.28% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Corcept Therapeutics Incorpora vs. Nuvalent
Performance |
| Timeline |
| Corcept Therapeutics |
| Nuvalent |
Corcept Therapeutics and Nuvalent Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Corcept Therapeutics and Nuvalent
The main advantage of trading using opposite Corcept Therapeutics and Nuvalent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corcept Therapeutics position performs unexpectedly, Nuvalent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvalent will offset losses from the drop in Nuvalent's long position.| Corcept Therapeutics vs. Ideaya Biosciences | Corcept Therapeutics vs. AnaptysBio | Corcept Therapeutics vs. MeiraGTx Holdings PLC | Corcept Therapeutics vs. Keros Therapeutics |
| Nuvalent vs. Arcellx | Nuvalent vs. Vaxcyte | Nuvalent vs. Viridian Therapeutics | Nuvalent vs. Ventyx Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |